Skip to content

Summit Therapeutics Inc.

SMMT Nasdaq SEC CIK 1599298

Follow Summit Therapeutics Weekly email: filings, results, news

News

10 stories filed under Summit Therapeutics, grouped into ongoing threads

Cancer

Thread · 4 stories

November 14 Is The Make-Or-Break Moment For Summit Therapeutics' Cancer Bet

Markets 21 d ago

Summit Therapeutics: Signals Of Moving Past Lung Cancer (Rating Upgrade)

Markets 29 d ago

Summit Therapeutics stock jumps on partner’s cancer trial data

Markets 29 d ago 2 sources

Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)’s Cancer Drug Partnership Create a New Treatment Standard?

Markets 41 d ago also on RCUS

More coverage

UBS reiterates Buy on Summit Therapeutics stock, $33 target

Markets 15 d ago 2 sources also on UBS

Summit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress

Markets 17 d ago

Summit Therapeutics: The High Stakes Of Translating China Clinical Data To The U.S.

Markets 20 d ago

Bernstein upgrades Summit Therapeutics stock rating on valuation

Markets 29 d ago 4 sources

Summit Therapeutics stock hits 52-week low at 12.23 USD

Markets 37 d ago 3 sources

The most popular Chinese car brands in Britain: From small fry to the maker selling 1 in 25 of all new cars

Markets 46 d ago

Next results

OCT21

Q3 2026 results

Wednesday · estimated from the filing cadence

Profile

Headquarters: MIAMI, FL, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 10 stories clustered from the RSS aggregator